Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05226117
Title Sacituzumab Govitecan, Preceding Radical Cystectomy, in Treating Patients With Muscle-invasive Bladder Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors IRCCS San Raffaele

transitional cell carcinoma


Sacituzumab govitecan-hziy

Age Groups: adult | senior
Covered Countries ITA

No variant requirements are available.